NDRG2 and malignant colon neoplasm: In this study, we analyzed NDRG2 promoter methylation using PSQ technique, because the sequence, reported to be a target of aberrant methylation in colon cancer (Piepoli et al. 2009) and used in our MSP analysis, was found unmethylated in all meningioma samples analyzed.